R82.5
Elevated urine levels of drugs, medicaments and biological substances
Clinical Classification Guidelines
Inclusion Terms
- Elevated urine levels of catecholamines
- Elevated urine levels of indoleacetic acid
- Elevated urine levels of 17-ketosteroids
- Elevated urine levels of steroids
Medical Intelligence & Overview
ICD-10 code R82.5 refers to the presence of elevated levels of certain substances in urine, including drugs, medications, and biological compounds. This condition can be detected through laboratory testing and may provide important information about a person's metabolic state or medication use. Elevations in these substances can have various underlying causes and may reflect physiological changes, medication responses, or specific health conditions.
Causes & Symptoms
Clinical Causes: Use of prescribed medications such as steroids, catecholamines, or other drugs metabolized and excreted via urine Hormonal disorders leading to increased production or decreased clearance of biological substances like 17-ketosteroids and indoleacetic acid Metabolic conditions affecting steroid or catecholamine metabolism Certain tumors or neoplasms producing excess biological substances Dietary factors or supplements that influence urinary substance levels Kidney or urinary tract conditions impacting excretion of substances
Key Symptoms: No specific symptoms directly associated with elevated urine levels; findings are typically incidental during lab testing Possible indications of underlying conditions, such as hormonal imbalances or metabolic disorders Potential signs related to the underlying cause, such as hormonal symptoms or metabolic disturbances
Diagnostic & Treatment
Diagnosis Path: The diagnosis is primarily established through laboratory urine tests that measure the levels of specific substances. These tests evaluate substances like catecholamines, indoleacetic acid, 17-ketosteroids, and steroids. Additional assessments may include blood tests, imaging, or biopsies to determine underlying causes and associated conditions.
Treatment Protocols: Management depends on the identified underlying cause. Treatment options may include adjusting or discontinuing certain medications, addressing hormonal imbalances, or treating metabolic disorders. Regular monitoring of urine substance levels can help track response to treatment and guide further interventions.
Clinical Advice & FAQs
Billing Guidance
Is R82.5 a billable ICD-10 code?
Yes, R82.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R82.5?
Clinical documentation must specify the nature of Elevated urine levels of drugs, medicaments and biological substances and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
